Bene Vobis Collagen VERISOL® (gelatin hydrolyzate) with vitamin C 250 g

The Bene Vobis Collagen VERISOL® (gelatin hydrolysate) with Vitamin C dietary supplement is a high-quality product containing valuable VERISOL® collagen and added vitamin C. VERISOL® is clinically proven and has a range of health-promoting properties. The Bene Vobis brand product has a simple, pure composition and is conveniently available in powder form.

VERISOL® is a type of collagen. One study investigated the effectiveness of this bioactive collagen peptide in inhibiting wrinkle formation around the eyes and stimulating the biosynthesis of collagen, elastin, and fibrillin in the skin. The intake of VERISOL®, which was used in this study, led to a significant reduction in wrinkle formation around the eyes. Furthermore, collagen supplementation had a positive effect on the synthesis of the dermal matrix. [1]

Vitamin C is a substance essential for collagen synthesis in the human body. It regulates one of the folding processes of this protein, allowing it to maintain its structure. In addition, ascorbic acid helps combat the negative effects of oxidative stress and supports the function of the nervous system [ID 133].

In summary, Bene Vobis Collagen VERISOL® (gelatin hydrolysate) with vitamin C is a high-quality product containing collagen hydrolysate powder - VERISOL® - and vitamin C. This preparation is characterized by its simple, pure composition without unnecessary additives or flavor enhancers.

1 Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral administration of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113-9. doi: 10.1159/000355523. Epub 2013 Dec 24. PMID: 24401291.

2 Hexsel D, Zague V, Schunck M, Siega C, Camozzato FO, Oesser S. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces the symptoms of brittle nails. J Cosmet Dermatol. 2017 Dec;16(4):520-526. doi: 10.1111/jocd.12393. epub 2017 Aug 8. PMID: 28786550.